Jubilant Pharmova Limited (JUBLPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 129.37B |
| Enterprise Value | 152.84B |
| P/E Ratio | 38.5 |
| PEG Ratio | -0.73 |
| Price/Sales Ratio | 1.85 |
| Price/Book Ratio | 2.16 |
| Enterprise/Revenue | 2.14 |
| Enterprise/EBITDA | 14.17 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 82.8B |
| Revenue/Share | 523.54 |
| Gross Profit | 24.94B |
| EBITDA | 12.66B |
| Net Income | 3.99B |
| Diluted EPS | 25.08 |
Balance Sheet
| Total Cash | 12.68B |
| Total Cash/Share | 80.15 |
| Total Debt | 36.15B |
| Total Debt/Equity | 0.51 |
| Current Ratio | 1.62 |
| Book Value Per Share | 448.67 |
Price History
| 52-Week Change | -18.88 |
| 52-Week High | 1,248 |
| 52-Week Low | 786.05 |
| Moving Average 50 Days | 979.26 |
| Moving Average 200 Days | 992.95 |
Statistics
| Average Volume | 111,548 |
| Shares Outstanding | 158.39M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 0.52 |
| Payout Ratio | 0.2 |
| Last Split Factor | 21:20 |
| Last Split Date | November 25, 2010 |
AD
